Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre L Triozzi

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal for Immunotherapy of Cancer|November 23, 2022
Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune responseElizabeth R Stirling, Masaki Terabe, Adam S Wilson, et al.
Cancer Biology & Therapy|March 9, 2005
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGNNikolay Korokhov, Tanja D de Gruijl, Wayne A Aldrich, et al.
Cancer|October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumorsAung Naing, Alain P Algazi, Gerald S Falchook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2022
Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint BlockadePierre L Triozzi, Elizabeth R Stirling, Qianqian Song, et al.
Cancer Genetics|December 3, 2014
Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognosticationEugen C Minca, Raymond R Tubbs, Bryce P Portier, et al.
Briefings in Bioinformatics|January 17, 2022
hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapyYong Lu, Gang Xue, Ningbo Zheng, et al.
Journal of Virology|December 3, 2003
Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridgeNikolay Korokhov, Galina Mikheeva, Alexander Krendelshchikov, et al.
Pigment Cell & Melanoma Research|August 13, 2014
Biology of advanced uveal melanoma and next steps for clinical therapeuticsJason J Luke, Pierre L Triozzi, Kyle C McKenna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal MelanomaNarges K Tafreshi, Christopher J Tichacek, Darpan N Pandya, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal for Immunotherapy of Cancer|November 23, 2022
Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune responseElizabeth R Stirling, Masaki Terabe, Adam S Wilson, et al.
Cancer Biology & Therapy|March 9, 2005
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGNNikolay Korokhov, Tanja D de Gruijl, Wayne A Aldrich, et al.
Cancer|October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumorsAung Naing, Alain P Algazi, Gerald S Falchook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2022
Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint BlockadePierre L Triozzi, Elizabeth R Stirling, Qianqian Song, et al.
Cancer Genetics|December 3, 2014
Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognosticationEugen C Minca, Raymond R Tubbs, Bryce P Portier, et al.
Briefings in Bioinformatics|January 17, 2022
hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapyYong Lu, Gang Xue, Ningbo Zheng, et al.
Journal of Virology|December 3, 2003
Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridgeNikolay Korokhov, Galina Mikheeva, Alexander Krendelshchikov, et al.
Pigment Cell & Melanoma Research|August 13, 2014
Biology of advanced uveal melanoma and next steps for clinical therapeuticsJason J Luke, Pierre L Triozzi, Kyle C McKenna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal MelanomaNarges K Tafreshi, Christopher J Tichacek, Darpan N Pandya, et al.
Pageof 6